These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 47179)

  • 21. Lymphocyte reactivity to influenza virus in man.
    Cole PJ; Molyneux ME
    Immunology; 1975 Oct; 29(4):749-54. PubMed ID: 1184119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A brief review of immune-response genes in mice.
    Günther E
    Transplant Proc; 1973 Dec; 5(4):1315-9. PubMed ID: 4130052
    [No Abstract]   [Full Text] [Related]  

  • 23. Major transplantation antigens, viruses, and specificity of surveillance T cells.
    Zinkernagel RM; Doherty PC
    Contemp Top Immunobiol; 1977; 7():179-220. PubMed ID: 69515
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological aspects of the pathogenesis of virus disease.
    Smith CE
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):177-84. PubMed ID: 4771767
    [No Abstract]   [Full Text] [Related]  

  • 25. MHC and non-MHC genes regulate elimination of lymphocytic choriomeningitis virus and antiviral cytotoxic T lymphocyte and delayed-type hypersensitivity mediating T lymphocyte activity in parallel.
    Thomsen AR; Marker O
    J Immunol; 1989 Feb; 142(4):1333-41. PubMed ID: 2783710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of T lymphocyte subsets in antiviral host defense.
    Leist TP; Cobbold SP; Waldmann H; Aguet M; Zinkernagel RM
    J Immunol; 1987 Apr; 138(7):2278-81. PubMed ID: 2435794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of viruses: antigenicity and evolution.
    Hope-Simpson RE
    Proc R Soc Med; 1969 Nov; 62(11 Part 1):1138-42. PubMed ID: 4311423
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte blast transformation response of seropositive and seronegative subjects to herpes simplex, rubella, mumps and measles virus antigens.
    Ilonen J
    Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):151-7. PubMed ID: 220840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmented immunogenicity of tumor cell homogenates produced by infection with influenza virus.
    Boone CW
    Natl Cancer Inst Monogr; 1972 Dec; 35():301-7. PubMed ID: 4349150
    [No Abstract]   [Full Text] [Related]  

  • 30. Cellular immune responses of human milk T lymphocytes to certain environmental antigens.
    Parmely MJ; Reath DB; Beer AE; Billingham RE
    Transplant Proc; 1977 Jun; 9(2):1477-83. PubMed ID: 69346
    [No Abstract]   [Full Text] [Related]  

  • 31. Lactate dehydrogenase-elevating virus: biology and pathogenesis.
    Cafruny WA
    Crit Rev Microbiol; 1989; 17(2):107-19. PubMed ID: 2692600
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
    J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis.
    McFarland HF; McFarlin DE
    Ann Neurol; 1979 Aug; 6(2):101-6. PubMed ID: 315204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between human lymphocytes and paramyxovirus-infected cells: adsorption and cytotoxicity.
    Härfast B; Andersson T; Stejskal V; Perlmann P
    J Immunol; 1977 Apr; 118(4):1132-7. PubMed ID: 300397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection.
    Kamperschroer C; Quinn DG
    Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serological study of the incidence of murine viruses in a population of small wild rodents (Microtus pennsylvanicus Ord, 1815)].
    Descôteaux JP
    Rev Sci Tech; 1992 Dec; 11(4):1071-7. PubMed ID: 1339064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summary and discussion of future applications of vaccination and immunotherapy.
    Allison AC
    Monogr Allergy; 1975; 9():259-71. PubMed ID: 163956
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of H-2 mutants as models for the study of T cell activation.
    McKenzie IF; Pang T; Blanden RV
    Immunol Rev; 1977; 35():179-230. PubMed ID: 70397
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA restriction of secondary mumps-specific cytotoxic T lymphocytes.
    Kress HG; Kreth HW
    J Immunol; 1982 Aug; 129(2):844-9. PubMed ID: 6177787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of human antilymphocytic serum in horse with thoracic duct lymphocytes and peripheral blood lymphocytes.
    Traeger J; Fries D; Revillard JP; Durix A; Carraz M; Plan M
    Fed Proc; 1970; 29(1):108-10. PubMed ID: 4904617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.